These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23410981)

  • 1. Reply to Michael A. Gorin, Arthur I. Sagalowsky and Mark S. Soloway's Letter to the Editor re: S. Picozzi, C. Ricci, M. Gaeta et al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. J Urol 2012; 188: 2046-54.
    Picozzi S; Ricci C; Carmignani L
    J Urol; 2013 Feb; ():. PubMed ID: 23410981
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients: S. Picozzi, C. Ricci, M. Gaeta, D. Ratti, A. Macchi, S. Casellato, G. Bozzini and L. Carmignani. J Urol 2012; 188: 2046-2054.
    Gorin MA; Sagalowsky AI; Soloway MS
    J Urol; 2013 Jul; 190(1):360-1. PubMed ID: 23410983
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Stefano C.M. Picozzi, Cristian Ricci and Luca Carmignani's letter to the editor re: Giacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol 2012;62:382-404.
    Novara G; Ficarra V
    Eur Urol; 2013 Feb; 63(2):e29-31. PubMed ID: 23218764
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Samuel Bishara and Jim Adshead's letter to the editor re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:839-45.
    Linder BJ; Boorjian SA
    Eur Urol; 2013 Sep; 64(3):e49-50. PubMed ID: 23787355
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Kaushik P. Kolanukuduru, Michael Gorin, Ash K. Tewari, and Mani Menon's Letter to the Editor re: Alec Zhu, Mary O. Strasser, Timothy D. McClure, et al. Comparative Effectiveness of Partial Gland Cryoablation Versus Robotic Radical Prostatectomy for Cancer Control. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.04.008.
    Strasser MO; Zhu A; Hu JC
    Eur Urol Focus; 2024 Sep; ():. PubMed ID: 39266376
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71. Can the Pattern of Cancer Recurrence Truly be Assigned to the Surgical Modality?
    Bochner BH; Dalbagni G
    Eur Urol; 2019 May; 75(5):e138-e139. PubMed ID: 30712972
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Gianluca Giannarini, Vincenzo Ficarra, and Claudio Valotto's Letter to the Editor re: Stephen B. Williams, Marcus G.K. Cumberbatch, Ashish M. Kamat, et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.06.039.
    Williams SB; Jubber I; Catto JWF; Daneshmand S
    Eur Urol; 2020 Nov; 78(5):e190-e191. PubMed ID: 32838998
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Michael Froehner, Rainer Koch and Manfred P. Wirth's letter to the editor re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012;62:662-70.
    Mayr R; May M; Fritsche HM
    Eur Urol; 2013 Jan; 63(1):e10. PubMed ID: 23079054
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Vladimir Novotny, Manfred P. Wirth, Michael Froehner's letter to the editor re: Atiqullah Aziz, Matthias May, Maximilian Burger, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 2014;66:156-163.
    Roghmann F; May M; Aziz A
    Eur Urol; 2014 Jul; 66(1):e14. PubMed ID: 24598014
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11.
    Gschwend JE; Heck M
    Eur Urol; 2019 Aug; 76(2):e37. PubMed ID: 31056229
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Farshad Pourmalek, Hamidreza Abdi, and Peter C. Black's Letter to the Editor re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol 2015;68:399-405.
    Nguyen DP; Scherr DS
    Eur Urol; 2016 Mar; 69(3):e36. PubMed ID: 26187784
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Mark C. Kendall's Letter to the Editor re: Karl H. Pang, Ruth Groves, Suresh Venugopal, Aidan P. Noon, James W.F. Catto. Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy. Eur Urol 2018;73:363-71.
    Pang KH; Groves R; Catto JWF
    Eur Urol; 2018 Sep; 74(3):e66. PubMed ID: 29866463
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Saeid Safiri and Erfan Ayubi's Letter to the Editor re: Nicholas J. Giacalone, William U. Shipley, Rebecca H. Clayman, et al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. Eur Urol 2017;71:952-60. Methodological Issues to Avoid Misinterpretation.
    Giacalone NJ; Niemierko A; Shipley WU; Efstathiou JA
    Eur Urol; 2017 Sep; 72(3):e64-e65. PubMed ID: 28642020
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Liang Sun and Yi Feng's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65: Importance of Surgical and Anesthesiological Standard Operating Procedures for Radical Cystectomy in a Bundled Care Setting.
    Vetterlein MW; Rink M
    Eur Urol; 2020 Jan; 77(1):e12-e13. PubMed ID: 31607396
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Santhanam Sundar's letter to the editor Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011;59:1009-18.
    Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA; Lebret T
    Eur Urol; 2012 Aug; 62(2):e45-6. PubMed ID: 22579356
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer.
    Vetterlein MW; Gild P; Fisch M; Rink M
    Eur Urol; 2020 Aug; 78(2):e77-e78. PubMed ID: 32376138
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9.
    Soria F; D'Andrea D; Gontero P; Shariat SF
    Eur Urol Focus; 2022 Mar; 8(2):633-634. PubMed ID: 33875390
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: James W.F. Catto, Pramit Khetrapal, Federico Ricciardi, et al. Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer: A Randomized Clinical Trial. JAMA 2022;327:2092-103: Lacking the Evidence for Neobladder Use After Radical Cystectomy.
    Catto JWF; Khetrapal P; Ambler G; Williams NR; Brew-Graves C; Kelly JD;
    Eur Urol; 2022 Dec; 82(6):e167-e168. PubMed ID: 36114078
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Mark C. Kendall's Letter to the Editor re: Marc A. Furrer, Adrian Fellmann, Marc P. Schneider, George N. Thalmann, Fiona C. Burkhard, Patrick Y. Wuethrich. Impact of Packed Red Blood Cells and Fresh Frozen Plasma Given During Radical Cystectomy and Urinary Diversion on Cancer-related Outcome and Survival: An Observational Cohort Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2017.09.010.
    Wuethrich PY
    Eur Urol Focus; 2019 Sep; 5(5):918-919. PubMed ID: 29937328
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Santosh Kumar and Aditya Prakash Sharma's letter to the editor re: Cheryl T. Lee, Sam S. Chang, Ashish M. Kamat, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial. Eur Urol 2014;66:265-72.
    Lee CT
    Eur Urol; 2015 Feb; 67(2):e30-1. PubMed ID: 25304758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.